Page 28 - The clinical aspects and management of chronic migraine Judith Anne Pijpers

26
Chapter 1
49. Natalie J Wiendels, Philip Spinhoven, Arie Knuistingh Neven, Frits R Rosendaal, Frans G Zitman, Willem J J Assendelft and MDF. The role of catastrophizing and locus of control in chronic frequent headache. Thesis, Leiden Univ Med Cent. 2008;chapter 4.
50. Wieser T, Walliser U, Womastek I, Kress HG. Dysfunctional coping in headache: Avoidance and endurance is not associated with chronic forms of headache. Eur J Pain. 2012;16:268-277. doi:10.1016/j.ejpain.2011.06.011
51. Wessman M, Terwindt GM, Kaunisto MA, Palotie A, Ophoff RA. Migraine: a complex genetic disorder. Lancet Neurol. 2007;6(6):521-532. doi:10.1016/S1474-4422(07)70126-6
52. Russell M, Iselius L, Olesen J. Migraine Without Aura and Migraine with Aura are Inherited Disorders. Cephalalgia. 1996;16(5):305-309. doi:10.1046/j.1468-2982.1996.1605305.x
53. Cologno D, De Pascale A, Manzoni GC. Familial Occurrence of Migraine With Aura in a Population- Based Study. Headache J Head Face Pain. 2003;43(3):231-234. doi:10.1046/j.1526-4610.2003.03046.x
54. Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38
susceptibility loci for migraine. bioRxiv. 2015;48(8):16-18. doi:10.1101/030288
55. Silberstein SD, Blumenfeld AM, Cady RK, et al. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache
medication overuse at baseline. J Neurol Sci. 2013;331(1-2):48-56. doi:10.1016/j.jns.2013.05.003
56. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study.
Cephalalgia. 2007;27(7):814-823. doi:10.1111/j.1468-2982.2007.01326.x
57. Munksgaard SB, Bendtsen L, Jensen RH. Detoxification of medication-overuse headache
by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia. 2012;32(11):834-844. doi:10.1177/0333102412451363
58. Chiang C-C, Schwedt TJ, Wang S-J, Dodick DW. Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2016;36(4):371-386. doi:10.1177/0333102415593088
59. Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication-overuse headache: A randomized controlled open-label trial. Cephalalgia. 2018;38(2):225-236. doi:10.1177/0333102417737779
60. Zeeberg, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006;26(10):1192-1198. doi:10.1111/j.1468- 2982.2006.01190.x
61. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs. structured detoxification programmes for medication overuse headache: A prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26(9):1097-1105. doi:10.1111/j.1468-2982.2006.01175.x
62. Rossi P, Faroni J V., Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2011;18(3):396-401. doi:10.1111/j.1468-1331.2010.03157.x
63. Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication- overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia. 2014;34(9):645- 655. doi:10.1177/0333102414521508
64. Bhola R, Goadsby PJ. A trans-cultural comparison of the organisation of care at headache centres world-wide. Cephalalgia. 2011;31(3):316-330. doi:10.1177/0333102410380756
65. Diener H-C, Gaul C, Jensen R, Göbel H, Heinze A, Silberstein S. Integrated headache care. Cephalalgia. 2011;31(9):1039-1047. doi:10.1177/0333102411409075
66. Gaul C, Van Doorn C, Webering N, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: An observational study. J Headache Pain. 2011;12(4):475-483. doi:10.1007/s10194-011-0348-y
67. Jensen R, Zeeberg P, Dehlendorff C, Olesen J. Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalalgia. 2010;30(10):1214-1224. doi:10.1177/0333102410361403
68. Kristoffersen ES. Brief intervention for medication-overuse headache in primary care. The BIMOH study: A double-blind pragmatic cluster randomised parallel controlled trial. J fur Neurol Neurochir und Psychiatr. 2015;16(1):38. doi:10.1136/jnnp-2014-308548
69. Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001;57(9):1694– 1698. doi:10.1212/WNL.57.9.1694